212 related articles for article (PubMed ID: 19264921)
1. The histone acetyl transferase activity of monocytic leukemia zinc finger is critical for the proliferation of hematopoietic precursors.
Perez-Campo FM; Borrow J; Kouskoff V; Lacaud G
Blood; 2009 May; 113(20):4866-74. PubMed ID: 19264921
[TBL] [Abstract][Full Text] [Related]
2. MOZ is essential for maintenance of hematopoietic stem cells.
Katsumoto T; Aikawa Y; Iwama A; Ueda S; Ichikawa H; Ochiya T; Kitabayashi I
Genes Dev; 2006 May; 20(10):1321-30. PubMed ID: 16702405
[TBL] [Abstract][Full Text] [Related]
3. Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells.
Thomas T; Corcoran LM; Gugasyan R; Dixon MP; Brodnicki T; Nutt SL; Metcalf D; Voss AK
Genes Dev; 2006 May; 20(9):1175-86. PubMed ID: 16651658
[TBL] [Abstract][Full Text] [Related]
4. Roles of the histone acetyltransferase monocytic leukemia zinc finger protein in normal and malignant hematopoiesis.
Katsumoto T; Yoshida N; Kitabayashi I
Cancer Sci; 2008 Aug; 99(8):1523-7. PubMed ID: 18754862
[TBL] [Abstract][Full Text] [Related]
5. The MYSTerious MOZ, a histone acetyltransferase with a key role in haematopoiesis.
Perez-Campo FM; Costa G; Lie-a-Ling M; Kouskoff V; Lacaud G
Immunology; 2013 Jun; 139(2):161-5. PubMed ID: 23347099
[TBL] [Abstract][Full Text] [Related]
6. The human monocytic leukemia zinc finger histone acetyltransferase domain contains DNA-binding activity implicated in chromatin targeting.
Holbert MA; Sikorski T; Carten J; Snowflack D; Hodawadekar S; Marmorstein R
J Biol Chem; 2007 Dec; 282(50):36603-13. PubMed ID: 17925393
[TBL] [Abstract][Full Text] [Related]
7. Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.
Shima H; Yamagata K; Aikawa Y; Shino M; Koseki H; Shimada H; Kitabayashi I
Int J Hematol; 2014 Jan; 99(1):21-31. PubMed ID: 24258712
[TBL] [Abstract][Full Text] [Related]
8. MOZ-mediated repression of p16(INK) (4) (a) is critical for the self-renewal of neural and hematopoietic stem cells.
Perez-Campo FM; Costa G; Lie-A-Ling M; Stifani S; Kouskoff V; Lacaud G
Stem Cells; 2014 Jun; 32(6):1591-601. PubMed ID: 24307508
[TBL] [Abstract][Full Text] [Related]
9. Expression of the MOZ-TIF2 oncoprotein in mice represses senescence.
Largeot A; Perez-Campo FM; Marinopoulou E; Lie-a-Ling M; Kouskoff V; Lacaud G
Exp Hematol; 2016 Apr; 44(4):231-7.e4. PubMed ID: 26854485
[TBL] [Abstract][Full Text] [Related]
10. Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2.
Liang J; Prouty L; Williams BJ; Dayton MA; Blanchard KL
Blood; 1998 Sep; 92(6):2118-22. PubMed ID: 9731070
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells.
Paggetti J; Largeot A; Aucagne R; Jacquel A; Lagrange B; Yang XJ; Solary E; Bastie JN; Delva L
Oncogene; 2010 Sep; 29(36):5019-31. PubMed ID: 20581860
[TBL] [Abstract][Full Text] [Related]
12. The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase.
Champagne N; Pelletier N; Yang XJ
Oncogene; 2001 Jan; 20(3):404-9. PubMed ID: 11313971
[TBL] [Abstract][Full Text] [Related]
13. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP.
Deguchi K; Ayton PM; Carapeti M; Kutok JL; Snyder CS; Williams IR; Cross NC; Glass CK; Cleary ML; Gilliland DG
Cancer Cell; 2003 Mar; 3(3):259-71. PubMed ID: 12676584
[TBL] [Abstract][Full Text] [Related]
14. MOZ is critical for the development of MOZ/MLL fusion-induced leukemia through regulation of Hoxa9/Meis1 expression.
Katsumoto T; Ogawara Y; Yamagata K; Aikawa Y; Goitsuka R; Nakamura T; Kitabayashi I
Blood Adv; 2022 Oct; 6(19):5527-5537. PubMed ID: 35947126
[TBL] [Abstract][Full Text] [Related]
15. Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.
Largeot A; Paggetti J; Broséus J; Aucagne R; Lagrange B; Martin RZ; Berthelet J; Quéré R; Lucchi G; Ducoroy P; Bastie JN; Delva L
Biochim Biophys Acta; 2013 Dec; 1833(12):3054-3063. PubMed ID: 23994619
[TBL] [Abstract][Full Text] [Related]
16. MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells.
Yang XJ; Ullah M
Oncogene; 2007 Aug; 26(37):5408-19. PubMed ID: 17694082
[TBL] [Abstract][Full Text] [Related]
17. Role of the MOZ/MLL-mediated transcriptional activation system for self-renewal in normal hematopoiesis and leukemogenesis.
Yokoyama A
FEBS J; 2022 Dec; 289(24):7987-8002. PubMed ID: 34482632
[TBL] [Abstract][Full Text] [Related]
18. MOZ and BMI1 act synergistically to maintain hematopoietic stem cells.
Sheikh BN; Metcalf D; Voss AK; Thomas T
Exp Hematol; 2017 Mar; 47():83-97.e8. PubMed ID: 27773671
[TBL] [Abstract][Full Text] [Related]
19. MOZ (KAT6A) is essential for the maintenance of classically defined adult hematopoietic stem cells.
Sheikh BN; Yang Y; Schreuder J; Nilsson SK; Bilardi R; Carotta S; McRae HM; Metcalf D; Voss AK; Thomas T
Blood; 2016 Nov; 128(19):2307-2318. PubMed ID: 27663673
[TBL] [Abstract][Full Text] [Related]
20. MOZ regulates B-cell progenitors and, consequently, Moz haploinsufficiency dramatically retards MYC-induced lymphoma development.
Sheikh BN; Lee SC; El-Saafin F; Vanyai HK; Hu Y; Pang SH; Grabow S; Strasser A; Nutt SL; Alexander WS; Smyth GK; Voss AK; Thomas T
Blood; 2015 Mar; 125(12):1910-21. PubMed ID: 25605372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
